Skip to main content
. 2010 Jan 8;3(1):110–124. doi: 10.3390/ph3010110

Figure 5.

Figure 5

Local administration and in vivo efficiency of PTD-NBD peptides in reduction of paw swelling in treated paws of DTH mouse. Analysis of therapeutic efficacy of NBD peptides in murine DTH arthritis model. Fifty µL of 200 µM PTD-NBD peptides (25 µg/paw) was injected in to right paw 2 h before antigen administration. Mice were monitored for paw thickness at 48 (a) and 72 h (b) after antigen administration (n = 10). Results were expressed as the percentage of control paw swelling. ** P < 0.001; * P <0.05.